Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Leukemia|April 24, 1999
Modulation of the immune response and tumor growth by activated RasS Weijzen, M P Velders, W M Kast
European Journal of Immunology|May 1, 1993
Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccinationW M Kast, R M Brandt, C J Melief
The Journal of Experimental Medicine|December 1, 1984
Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cellsW M Kast, L P de Waal, C J Melief
Seminars in Cancer Biology|April 3, 2002
Immunodominance and tumor escapeH Schreiber, T H Wu, J Nachman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Tracking the common ancestry of antigenically distinct cancer variantsK Schreiber, T H Wu, W M Kast, et al.
Leukemia|May 23, 2001
Prospect for immunotherapy of acute lymphoblastic leukemiaM P Velders, S A ter Horst, W M Kast
Current Opinion in Molecular Therapeutics|March 16, 2001
Notch signaling as a target in multimodality cancer therapyM S Jang, A Zlobin, W M Kast, et al.
Biochimica Et Biophysica Acta|December 20, 1982
The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidaseR Wever, W M Kast, J H Kasinoedin, et al.
Current Opinion in Immunology|October 1, 1996
Peptide-based cancer vaccinesC J Melief, R Offringa, R E Toes, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2W M Kast, R M Brandt, J W Drijfhout, et al.
Pageof 13